Climate Change Data

Breathe ESG

Climate Impact & Sustainability Data (2019, 2022, 2023)

Reporting Period: 2019

Environmental Metrics

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Climate Goals & Targets

Environmental Challenges

  • Data limitations in certain countries regarding environmental and social metrics.
Mitigation Strategies
  • Adoption of regional averages and data from comparable countries where detailed data is unavailable.
  • Methodological refinement in future updates.

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: SEEA-CF, SNA 2008, SF-MST (draft)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Not disclosed

Environmental Achievements

  • Not disclosed

Social Achievements

  • Not disclosed

Governance Achievements

  • Not disclosed

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Lack of funding for technology upgrades in the public sector.
  • Higher public scrutiny of technology adoption in the public sector.
  • Complex contracting processes for technology projects.
  • Lack of internal IT capacity in many public agencies.
  • Agency fragmentation and lack of coordination.
  • Uneven digital access among citizens.
  • Organizational silos hindering data integration.
  • Outdated IT infrastructure (legacy systems).
  • Cybersecurity concerns.
  • Difficulties in balancing the need for speed and efficiency with the need for deliberation and equity in technology adoption.
Mitigation Strategies
  • Increased funding for technology investments (e.g., American Rescue Plan).
  • Efforts to improve contracting processes and build internal IT capacity.
  • Development of integrated data systems and cloud-based data storage.
  • Initiatives to address digital equity and improve access to technology for all citizens.
  • Development of technology-specific policies and regulations (e.g., transparency and accountability measures).
  • Increased focus on worker and client involvement in technology design and implementation.
  • Emphasis on evaluating technology projects based on their impact on public services and public values.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed

Reporting Period: 2023

Environmental Metrics

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Dr. Reddy’s reported a 21% reduction in Scope 1 and Scope 2 GHG emission intensity in FY2022-23.
  • Shift from traditional batch manufacturing to continuous manufacturing reduced carbon emissions by 70-80%
  • Lupin Pharmaceuticals achieved Zero Liquid Discharge status in almost 50% of Indian manufacturing sites.
  • Biocon recorded 680,000 litres of incremental water savings per day across global manufacturing operations in 2021.
  • Sun Pharma committed to disposing of 30% of hazardous waste generated in a scientific and safe manner through co-processing by 2025.
  • Aurobindo Pharma implemented packaging reduction resulting in a 60% pack size reduction and 80% material consumption reduction.

Social Achievements

  • Many leading pharmaceutical companies are improving access to medicine in low- and middle-income countries.
  • GlaxoSmithKline unveiled a £1 billion R&D investment for infectious diseases affecting lower-income nations.

Governance Achievements

  • 38% of Indian pharma companies actively publish dedicated Sustainability or ESG reports.
  • Approximately 43% of Indian pharma companies have a dedicated ESG or Sustainability Governance Committee.

Climate Goals & Targets

Medium-term Goals:
  • AstraZeneca committed to achieving carbon negativity within its supply chain by 2030.
  • Pfizer's target of carbon neutrality by 2030.
Short-term Goals:
  • Cipla and Glenmark aim to become carbon neutral by 2025 and 2030 respectively.

Environmental Challenges

  • Increasing scrutiny over ESG performance can deter investment.
  • Monetary penalties for non-compliance.
  • Inconsistent reporting practices and risk of 'greenwashing'.
  • Risks from climate-related events damaging assets and disrupting supply chains.
  • New laws and regulations related to ESG issues increasing compliance costs.
Mitigation Strategies
  • Diversify revenue streams and support the transition to green energy.
  • Implement robust ESG strategies and transparent reporting.
  • Formulate and implement proactive climate change mitigation strategies.
  • Maintain thorough awareness and understanding of the latest regulations and ensure consistent, comprehensive compliance.

Supply Chain Management

Responsible Procurement
  • Evaluating and onboarding vendors adopting quality and Current Good Manufacturing Practices (cGMP)

Climate-Related Risks & Opportunities

Physical Risks
  • Increasing frequency and severity of climate-related events damaging assets and disrupting supply chains
Transition Risks
  • New laws and regulations related to ESG issues

Reporting Standards

Frameworks Used: BRSR